Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...

Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...

Earnings jumped to $1.03 a share, up from $0.60 a year ago, as Emerson ( NYSE: EMR) improved its pretax margin by 570 basis ...

US stocks inched higher amid a tough batch of corporate earnings after the bell and persistent trade uncertainty.

Walt Disney posted better-than-expected results for April through June and raised its full-year earnings guidance on ...

Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.

Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

Second Quarter 2025 Results Key Financial Results Revenue: US$14.7b (up 10% from 2Q 2024).

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

The company put up a bottom-line revenue that not only exceeded Wall Street expectations, but also its own history of ...

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...

Portfolio status: 100% of loans were performing as of Q2 2025; weighted average risk rating held steady at 2.9, with no ...